The Cancer Forum invites abstracts for oral presentations, poster presentations, and symposia. Abstracts should contain original research findings such as data from:  descriptive or observational studies (quantitative, qualitative, or mixed method designs); experiments such as randomized controlled trials, pilot studies, case studies, or other empirical evaluations of an intervention, program, policy, or experimental condition; evaluations of feasibility, dissemination, implementation, or sustainability of new or existing intervention, practice guideline, or health policy; or any combination of the above.

Special consideration will be given to research pertaining to this year’s conference theme, “Creating the Healthiest Nation: Health Equity Now,” as well as topics relevant to APHA forums or special interest groups with whom the Cancer Forum has a history of hosting joint or collaborative sessions (e.g., Alcohol and Tobacco Use, Epidemiology, Global/International Health, Mens Health Caucus, Womens Caucus). Topics that are relevant to the conference theme and/or the broader mission of the Cancer Forum include:

• Cancer Prevention
  Enhancing Cancer Prevention efforts (e.g., identification of genetic, socioeconomic, environmental, or behavioral risk factors; early interventions targeting risk factors such as tobacco use, physical activity, exposures to environmental toxins, or nutrition)
• Cancer Screening or Diagnosis
  Improving Cancer Screening or Diagnosis (e.g., evaluation of community outreach programs to increase screening rates; examining technological advancements to improve cancer detection and diagnosis)
• Clinical Care and Cancer Survivorship
  Advancing Clinical Care and Treatment for cancer and associated complications (e.g., clinical trials examining cancer therapeutics; advancements in precision medicine) AND/OR Describing Cancer Survivorship concerns or developing resources for cancer survivors and caregivers (e.g., evaluation of social and instrumental support in long-term outcomes; interventions designed to improve quality of life for survivors and caregivers)
• Health Equity and Disparities
  Promoting or identifying areas of Health Equity (e.g., evaluation of factors or programs that promote fair access to levels of care across the cancer care continuum) AND/OR Examining or eliminating Health Disparities (e.g., quantifying at-risk subpopulations or barriers to care such as limited access or low health literacy)
• Laws, Guidelines, and Policies
  Evaluating Laws, Guidelines, and Policies that reduce the public health burden of cancer (e.g., improving access to or affordability of screening and treatment; tobacco control regulations; controversies in treatment and prevention guidelines)

Submitted abstracts will be evaluated based on their conceptual and methodological quality, innovation and novelty, and relevance to the conference theme. Abstracts submitted to the Cancer Forum are required to include quantitative and/or qualitative data to be considered for acceptance. Preliminary or pilot data are acceptable, but proposed projects or abstracts with no data at all to report at the time of the abstract deadline will be rejected.

Abstracts are limited to 250 words or less.

Referral to web pages or URLs may not be used for abstracts.

An author may not submit the same abstract to more than one Section, SPIG, Caucus, or Forum.

Preferences for oral versus poster presentation will be considered, but the program committee will consider all abstracts for both oral and poster categories. Oral presentations at contributed sessions are generally 13-15 minutes in length. An additional 3-5 minutes will be available for discussion and questions from the audience. Presenters at poster sessions should display their work and be available to answer questions throughout the scheduled 60 minute poster session.

If you are interested in submitting a panel/symposium for consideration as part of the 2018 APHA Cancer Forum program, please contact the Program Planners (contact info below) for additional instructions. For any and all inquiries about your abstract, always refer to the abstract number assigned to you by the online system.

Continuing Education Credit:

APHA values the ability to provide continuing education credit to physicians, nurses, health educators, and those certified in public health at its annual meeting. Please complete all required information when submitting an abstract so members can claim credit for attending your session. These credits are necessary for members to keep their licenses and credentials.

For a session to be eligible for Continuing Education Credit, each presenter, panelist, discussant, and/or faculty must provide:

1) an abstract free of trade and/or commercial product names;

2) at least one MEASURABLE SINGLE outcome (“to understand” or “to learn” are not measurable outcomes and compound outcomes are not acceptable). Use ONLY the following Measurable Action Verbs: Explain, Demonstrate, Analyze, Formulate, Discuss, Compare, Differentiate, Describe, Name, Assess, Evaluate, Identify, Design, Define or List.

 3) A signed Conflict of Interest Disclosure Form with a relevant qualification statement;

Example of Acceptable Biographical Qualification Statement: “I have been the principal or co-principal of multiple federally funded grants focusing on the epidemiology of drug abuse, HIV prevention and co-occurring mental and drug use disorders. Among my scientific interests has been the development of strategies for preventing HIV and STDs in out-of-treatment drug users.” Please note that “I am the Principle Investigator of this study” is NOT an acceptable qualification statement.

 4) All continuing education learning content must be of sound science or professional practice and serve to maintain, develop, or increase the knowledge, skills and professional competence of the health professional. Learning content should be evidence-based if available. A list of over 30 areas will be provided online for you to choose from. You will be asked to choose at least one or up to 6 areas that your presentation will address.

Thank you for your assistance in making your session credit worthy. Contact Mighty Fine at mighty.fine@apha.org if you have any questions concerning continuing education. For program questions, contact the program planner listed below.

---

Ready?

Program Planner Contact Information:

Heather McGinty, PhD
James Cancer Hospital and Solove Research Institute
The Ohio State UniversityOH 43210
Phone: 614-688-7228
Heather.McGinty@osumc.edu

and
Adriana Babiak-Vazquez
ababiakv_v@swbell.net